PIM1 antibody (N-Term)
Quick Overview for PIM1 antibody (N-Term) (ABIN630674)
Target
See all PIM1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- PIM1 antibody was raised against the N terminal of PIM1
-
Purification
- Affinity purified
-
Immunogen
- PIM1 antibody was raised using the N terminal of PIM1 corresponding to a region with amino acids MLLSKINSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
PIM1 Blocking Peptide, (ABIN5615379), is also available for use as a blocking control in assays to test for specificity of this PIM1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of PIM1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- PIM1 (Pim-1 Oncogene (PIM1))
-
Alternative Name
- PIM1
-
Background
- PIM1 may affect the structure or silencing of chromatin by phosphorylating HP1 gamma/CBX3. Isoform 2 promotes the G1/S transition of the cell cycle via up-regulation of CDK2 activity and phosphorylation of CDKN1B.
-
Molecular Weight
- 36 kDa (MW of target protein)
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-